September 15, 2026 | Tr1X, Inc. to Highlight Miltenyi Biotec CDMO Capabilities for Scalable Allogeneic Cell Therapy Manufacturing at the 11th Annual CAR-TCR Summit
November 11, 2024 | Miltenyi Biotec to commercially supply CliniMACS® Platform to Autolus Therapeutics for its manufacture of FDA-approved AUCATZYL® (obecabtagene autoleucel – obe-cel)
February 27, 2024 | Miltenyi Biotec opens its first office in India and plans to invest in first of its kind Cell and Gene Therapy Center of Excellence
December 18, 2023 | Miltenyi Biotec and Replay’s Syena agree on exclusive licensing and GMP manufacturing using CliniMACS Prodigy® for PRAME TCR-NK cell therapy